Clinical Trials for HER2-negative Breast Cancer Patients with Brain Metastases

Find clinical trials for her2-negative breast cancer patients with brain metastases. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients with Brain Metastases

NCT ID: NCT06764940

This clinical trial is studying a new treatment for patients with HER2-negative breast cancer that has spread to the brain. The treatment being tested combines two medications: utidelone and capeci...

Recruiting

Phase: PHASE2 Type: interventional Locations: Oxnard, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions